Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 180   

Articles published

MRK 66.02 +0.56 (0.86%)
price chart
Merck: Why The Small Dividend Hikes?
Merck's dividend was never cut after the crisis but it hasn't grown much either. Merck has lots of priorities for its cash and as a result, its dividend takes a back seat to an extent.
Merck & Co., Inc. (MRK): What's the Story?  StockNewsJournal
Merck & Co., Inc. (MRK) is up 14.83% on its 52-week low  NY Stock News
EOD Risers: Merck & Co., Inc., Microsoft Corporation, Nike Inc
The share price for Merck & Co., Inc. EPIC code: (NYSE:MRK) a global healthcare company, climbed 1.44% or 0.93 points during yesterday's session.
Merck Reveals Its Gastric Cancer Hand
Merck & Co (NYSE:MRK) recently made an audacious bid to gain early approval for Keytruda in gastric cancer, potentially outmaneuvering immuno-oncology competitors with the first regulatory OK, and the data backing this were disclosed at Asco today.
Digging Up the Facts on Merck & Co., Inc. (MRK)
Merck & Co., Inc. (MRK) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers - Major.
Are Analysts Bearish Merck & Co., Inc. (NYSE:MRK) After Last Week?  WeeklyHub
Merck & Co., Inc. (MRK) Closed at $65.46  HugoPress
Merck & Co., Inc. (MRK) moves above 100 DMA
Merck & Co., Inc. (MRK) has been having a set of eventful trading activity and it is clear from an examination of the charts that traders are now fully aware of the company's key metrics.
Merck Wows Investors With Stellar Q1 Performance
Merck (NYSE:MRK) is one of those very few companies that has not only reported strong financial performance in Q1 2017 but also raised its 2017 revenue and EPS guidance.
Merck announces follow-up data with Merck's KEYTRUDA
Merck (MRK) announces updated results from KEYNOTE-021, Cohort G1, which studied KEYTRUDA (pembrolizumab), the company's anti-PD-1 therapy, in combination with pemetrexed and carboplatin (pem/carbo) in the first-line treatment of patients with ...
Merck & Co. Inc.: New Data Show Durability of Response for Merck's ...  The Wall Street Transcript
Merck & Co., Inc. (MRK) is up on 200 DMA
Merck & Co., Inc. (MRK) is now trading with a very clear set of technicals. Taken together they paint a very compelling picture of how investors and traders should be approaching MRK.
As Merck & Co INC (MRK) Stock Price Declined, Sanders Capital LLC Has ...  Weekly Register
Merck & Company, Inc. (MRK) Shares Bought by Reliance Trust Co. of Delaware  The Cerbat Gem
Why Investors remained buoyant on: Merck & Co., Inc. (MRK), Wal-Mart Stores ...
Merck & Co., Inc. (NYSE:MRK) market capitalization at present is $177.12B at the rate of $64.53 a share. The firm's price-to-sales ratio was noted 4.36 in contrast with an overall industry average of 3.64.
EOD Risers: JPMorgan Chase & Co., McDonald's Corporation, Merck & Co., Inc.
Merck & Co., Inc. now has a 20 simple moving average of 64.66 and also a 50 day simple moving average now at 63.93.